Chemistry:Suvratoxumab
From HandWiki
Short description: Monoclonal antibody
| Monoclonal antibody | |
|---|---|
| Type | ? |
| Source | Human |
| Target | Staphylococcus aureus alpha toxin |
| Clinical data | |
| Other names | MEDI4893 |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Formula | C6556H10114N1730O2100S44 |
| Molar mass | 148179.68 g·mol−1 |
Suvratoxumab (INN;[1] development code MEDI4893) is a human monoclonal antibody designed for the prevention of nosocomial pneumonia caused by Staphylococcus aureus.
This drug was developed by MedImmune[2]
References
- ↑ World Health Organization (2016). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 116". WHO Drug Information 30 (4). https://www.who.int/medicines/publications/druginformation/innlists/PL116.pdf.
- ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Suvratoxumab, American Medical Association.
 |  |
